UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 23, 2026
Exercise
Calculated transaction value
$0
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 22, 2026
Public filing date
Jul 23, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$527.07
Jul 22, 2026
Close before public filing
$527.07
Jul 22, 2026
Return since public filing
-7.49%
Through Sep 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 9,500 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000104
Filing cohort
Transactions in this filing
Showing 15 of 16
Trades
16
Issuers
1
Estimated value
$6.33M
Buys / sales
0 / 14
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Jul 22, 2026 | $423.83K |
| United Therapeutics Corp UTHR | Exercise | Jul 22, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jul 22, 2026 | $62.91K |
| United Therapeutics Corp UTHR | Sale | Jul 22, 2026 | $255.13K |
| United Therapeutics Corp UTHR | Sale | Jul 22, 2026 | $1.38M |
| United Therapeutics Corp UTHR | Sale | Jul 22, 2026 | $639.19K |
| United Therapeutics Corp UTHR | Sale | Jul 22, 2026 | $462.26K |
| United Therapeutics Corp UTHR | Sale | Jul 22, 2026 | $402.64K |
| United Therapeutics Corp UTHR | Sale | Jul 22, 2026 | $212.49K |
| United Therapeutics Corp UTHR | Sale | Jul 22, 2026 | $260.76K |
| United Therapeutics Corp UTHR | Sale | Jul 22, 2026 | $173.08K |
| United Therapeutics Corp UTHR | Sale | Jul 22, 2026 | $57.29K |
| United Therapeutics Corp UTHR | Sale | Jul 22, 2026 | $306.43K |
| United Therapeutics Corp UTHR | Sale | Jul 22, 2026 | $366.15K |
| United Therapeutics Corp UTHR | Sale | Jul 22, 2026 | $43.16K |